Literature DB >> 22066691

Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer.

Kavita Sail1, Luisa Franzini, David Lairson, Xianglin Du.   

Abstract

OBJECTIVE: To examine racial disparities associated with breast cancer treatment and survival in elderly patients with early stage operable breast cancer.
METHODS: We studied 23,110 women with node-positive and 31,572 women with node-negative tumor who were aged ≥65 with stages I, II, or IIIA breast cancer in 1991-2002 using the Surveillance, Epidemiology and End Results (SEER)-Medicare linked data. Logistic regression analyses were performed to assess the odds of receiving adjuvant chemotherapy and radiation after breast conserving surgery (BCS) for blacks compared to whites. Cox proportional hazard regression models were used to determine the risk of mortality in blacks compared to whites, stratified by types of treatment.
RESULTS: Black women with node-positive and node-negative tumors were 25% (odds ratio = 0.75, 95% CI = 0.65-0.87) and 17% (0.83, 0.70-0.99) less likely to receive chemotherapy than white women, after adjusting for patient and tumor characteristics. This relation was not attenuated and remained statistically significant even after adjustment for socioeconomic status. In women with node-negative tumor who did not receive chemotherapy, black women were significantly more likely to die than white women (hazard ratio (HR) = 1.14, 95% CI = 1.04-1.24) after adjusting for patient and tumor characteristics, and comorbidity; and (1.11, 1.01-1.22) after additionally adjusting for socioeconomic status.
CONCLUSIONS: There were racial disparities between black and white women in receiving adjuvant chemotherapy and radiotherapy following BCS. Higher risk of mortality in black compared to white women was found only in those receiving no chemotherapy. Future studies should explore the root causes of racial disparities beyond treatment factors.

Entities:  

Mesh:

Year:  2011        PMID: 22066691     DOI: 10.1080/13557858.2011.628011

Source DB:  PubMed          Journal:  Ethn Health        ISSN: 1355-7858            Impact factor:   2.772


  16 in total

1.  Racial/ethnic differences in the relative risk of receipt of specific treatment among men with prostate cancer.

Authors:  Kelvin A Moses; Heather Orom; Alicia Brasel; Jacquelyne Gaddy; Willie Underwood
Journal:  Urol Oncol       Date:  2016-05-06       Impact factor: 3.498

2.  Socioeconomic disparities in breast cancer treatment among older women.

Authors:  Arica White; Lisa C Richardson; Helen Krontiras; Maria Pisu
Journal:  J Womens Health (Larchmt)       Date:  2013-12-19       Impact factor: 2.681

3.  Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression.

Authors:  Candyce H Kroenke; Carol Sweeney; Marilyn L Kwan; Charles P Quesenberry; Erin K Weltzien; Laurel A Habel; Adrienne Castillo; Phillip S Bernard; Rachel E Factor; Lawrence H Kushi; Bette J Caan
Journal:  Breast Cancer Res Treat       Date:  2014-03-07       Impact factor: 4.872

4.  Racial/ethnic differences in the utilization of chemotherapy among stage I-III breast cancer patients, stratified by subtype: Findings from ten National Program of Cancer Registries states.

Authors:  Lu Zhang; Jessica King; Xiao-Cheng Wu; Mei-Chin Hsieh; Vivien W Chen; Qingzhao Yu; Elizabeth Fontham; Michelle Loch; Lori A Pollack; Tekeda Ferguson
Journal:  Cancer Epidemiol       Date:  2018-11-08       Impact factor: 2.984

5.  Psychosocial correlates of appointment keeping in immigrant cancer patients.

Authors:  Rosario Costas-Muniz; Jennifer Leng; Lisa Diamond; Abraham Aragones; Julia Ramirez; Francesca Gany
Journal:  J Psychosoc Oncol       Date:  2015-01-09

6.  Breast cancer survival in African-American women by hormone receptor subtypes.

Authors:  Tomi Akinyemiju; Justin Xavier Moore; Sean F Altekruse
Journal:  Breast Cancer Res Treat       Date:  2015-08-07       Impact factor: 4.872

7.  Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage.

Authors:  Lu Chen; Hannah M Linden; Benjamin O Anderson; Christopher I Li
Journal:  Breast Cancer Res Treat       Date:  2014-08-28       Impact factor: 4.872

8.  Breast cancer clinical characteristics and outcomes in Trinidad and Tobago.

Authors:  Marlene Camacho-Rivera; Camille Ragin; Veronica Roach; Tricia Kalwar; Emanuela Taioli
Journal:  J Immigr Minor Health       Date:  2015-06

9.  Improving healthcare empowerment through breast cancer patient navigation: a mixed methods evaluation in a safety-net setting.

Authors:  Guzyal Gabitova; Nancy J Burke
Journal:  BMC Health Serv Res       Date:  2014-09-19       Impact factor: 2.655

10.  Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010.

Authors:  Carol A Parise; Vincent Caggiano
Journal:  BMC Cancer       Date:  2013-10-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.